Comparative Effectiveness Between Microprocessor Knees and Non-Microprocessor Knees (MPK-AOPA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02240186 |
|
Recruitment Status :
Completed
First Posted : September 15, 2014
Results First Posted : December 12, 2018
Last Update Posted : December 12, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Lower Limb Amputation Above Knee (Injury) | Device: Microprocessor Knee (MPK) Device: Non-Microprocessor Knee (NMPK) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 50 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Comparative Effectiveness Between Microprocessor Knees and Non-Microprocessor Knees |
| Actual Study Start Date : | June 2014 |
| Actual Primary Completion Date : | June 2017 |
| Actual Study Completion Date : | December 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Prosthetic knee joints
Each subject will be tested using their current Non-Microprocessor Knee (NMPK) , fit and tested with a Microprocessor Knee (MPK), and then tested again with their NMPK, e.g. A-B-A design.
|
Device: Microprocessor Knee (MPK)
MPKs are prosthetic knees that use a microprocessor to control the prosthetic knee mechanism and adjust knee stiffness. Device: Non-Microprocessor Knee (NMPK) A NMPK is a mechanical knee with either hydraulic or pneumatic controls. |
- Daily Activity Measured With Triaxial Accelerometers [ Time Frame: Baseline (tested on subjects' current NMPK), 10 weeks (after 10 weeks acclimation time to the study MPK) , 4 weeks (subjects placed back on NMPK and tested after 4 weeks re-acclimation time) ]Measurements will be obtained three times using activity monitors attached to waist, and bilaterally to the ankle and thigh for a period of 4 consecutive days, including 2 weekdays and 2 weekend days. Primary outcome will be the difference in activity level between the NMPK and MPK measurements.
- Falls as Assessed by the Prosthesis Evaluation Questionnaire Addendum (PEQ-A) [ Time Frame: Baseline (tested on subjects' current NMPK), 10 weeks (after 10 weeks acclimation time to the study MPK) , 4 weeks (subjects placed back on NMPK and tested after 4 weeks re-acclimation time) ]The Prosthesis Evaluation Questionnaire (PEQ) addendum (PEQ-A) is a self-administered questionnaire to quantify balance confidence, concentration, stumbles, and falls. The outcome will be difference in falls per month between the Non-Microprocessor Knee (NPMK) and MPK measurements. The number of falls was recorded as the sum of items #5 and #7 in the PEQ-A.
- Patient Satisfaction as Assessed by the Prosthesis Evaluation Questionnaire (PEQ) [ Time Frame: Baseline (tested on subjects' current NMPK), 10 weeks (after 10 weeks acclimation time to the study MPK) , 4 weeks (subjects placed back on NMPK and tested after 4 weeks re-acclimation time) ]
The condition-specific Prosthesis Evaluation Questionnaire (PEQ) was used to quantify patient satisfaction with each prosthesis. The outcome was a difference in PEQ scores between the NPMK and MPK measurements.
The PEQ is a self-administered questionnaire composed of nine validated scales (ambulation, appearance, frustration, perceived response, residual limb health, social burden, sounds, utility, well being). Scores range from 0 to 100 for each sub-scale. Higher scores indicated a higher functioning prosthesis/quality of life.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Unilateral transfemoral amputee
- Medicare Functional Classification Level K2 or K3
- Currently using NMPK prosthesis
- No current residual limb problems, such as skin breakdown
- Able to ambulate without a gait aid
Exclusion Criteria:
- Previous stroke or other neuromuscular complications currently affecting gait
- Currently undergoing dialysis treatments
- Amputation of the contralateral limb
- Poor fit of current NMPK prosthesis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02240186
| United States, Minnesota | |
| Mayo Clinic | |
| Rochester, Minnesota, United States, 55905 | |
| Principal Investigator: | Kenton R Kaufman, PhD | Mayo Clinic |
Documents provided by Kenton R. Kaufman, Ph.D., Mayo Clinic:
| Responsible Party: | Kenton R. Kaufman, Ph.D., Professor of Biomedical Engineering, College of Medicine, Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT02240186 |
| Other Study ID Numbers: |
14-002930 Foundation ( Other Grant/Funding Number: American Orthotic and Prosthetic Association ) |
| First Posted: | September 15, 2014 Key Record Dates |
| Results First Posted: | December 12, 2018 |
| Last Update Posted: | December 12, 2018 |
| Last Verified: | December 2018 |
|
Microprocessor-controlled knee prosthesis amputation |

